What does it do?
This product is used in the treatment of osteoporosis. It works by inhibiting the osteoclasts which break down the bone.
Last text update: 2011-10-04
Last data update: 2012-01-14
Usage:
Fosamax Plus D is most commonly used to treat the conditions below, together with the percentage of all people taking the medication for the particular condition.
| Disease/Condition | % |
|---|
| Osteoporosis | 88% |
| Rheumatoid Arthritis | 4% |
| Bone Loss Prevention | 4% |
General Information:
- 5.0
- Fosamax Plus D Average Satisfaction Score
- 51% of patients are at least somewhat satisfied with Fosamax Plus D.
MediGuard regularly polls our more than 700 users taking Fosamax Plus D (or similar drugs with the same active ingredient(s)) using the Treatment Satisfaction Questionnaire for Medications (TSQM). This feedback is continuously updated for the benefit of the MediGuard community. To request scores for specific patient subgroups, please contact research@mediguard.org.
Comments
Global Patient Feedback for Fosamax Plus D
Please see our forum guidelines.
I was on Fosomax D for over 2 years. In that time I had developed pain in all of my joints. Starting with my wrists and ending with me having to crawl up the stairs because my knees were in so much pain. Vision problems and leg cramps were also an issue. I went to the same Dr. over this span and she did not realize that Fosomax was the problem until I found all the information online. I went off the medication and it took about 18 months for all of the symptoms to finally go away. My bone density tests showed bone loss so I had to take something. I am now on Evista. This causes hot flashes and weight gain. That I can live with.
- 59 year old – Source: MediGuard
- Posted: 2011-03-11 08:50:03
Is loss of hair listed as apossible side effect?
- 78 year old – Source: MediGuard
- Posted: 2010-03-29 15:37:31
My hair has stopped falling out when I quite taking Fosamax and slight growth in thinist places
- 77 year old – Source: MediGuard
- Posted: 2009-03-30 14:18:58
Ask Us

